Views:

 

Launch of PMS Public API User Acceptance Testing (UAT) Call for Expression of Interest

EMA invites public stakeholders to apply to the first PMS Public API UAT planned for February 2026
 
date: 09/12/2025
 

The European Medicines Agency (EMA) is pleased to announce the launch of a Call for Expressions of Interest inviting public stakeholders to participate in the User Acceptance Testing (UAT) of the Product Management Service (PMS) Public API (Application Programming Interface), planned for February 2026. 

This initiative represents the first publicly accessible UAT for PMS, marking an important milestone towards open and interoperable access to structured medicinal product data across the EU. 

Public and international organisations, data and standards bodies, software and system developers, and Patient and Healthcare Professional Groups are encouraged to express their interest in joining the UAT, which will focus on evaluating technical interoperability and ease of use for public and external data consumers.

The deadline for submitting nominations is 12 January 2026 (end of day).

For more information on scope, eligibility criteria, timeline, and how to apply, please consult the official Call for Expression of Interest for PMS Public API UAT, available at this link.